A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis

Autor: Younis, Brima M., Wiggins, Rebecca, Khalil, Eltahir A.G., Osman, Mohamed, Santoro, Francesco, Sonnati, Chiara, Keding, Ada, Novedrati, Maria, Montesi, Giorgio, Noureldein, Ali, Elmukashfi, Elmukashfi T.A., Mustafa, Ala Eldin, Alamin, Mohammed, Saeed, Mohammed, Salman, Khalid, Suliman, Ahmed J., Musa, Amin E.A., Layton, Alison M., Lacey, Charles J.N., Kaye, Paul M., Musa, Ahmed M.
Zdroj: In Molecular Therapy - Methods & Clinical Development 12 September 2024 32(3)
Databáze: ScienceDirect